Consensus Codexis, Inc.

Stocks

CDXS

US1920051067

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-08-24 EDT			5-day change	1st Jan Change
1.660 ^USD	-0.60%		+4.40%	+1.84%

08-11	Codexis, Inc., Q2 2026 Earnings Call, Aug 11, 2026
08-11	Codexis, Inc. Reaffirms Earnings Guidance for the Full Year 2026	CI

Evolution of the Average Target: Codexis, Inc.

Evolution of the Target Price: Codexis, Inc.

Changes in Analyst Recommendations: Codexis, Inc.

19.wZZW-f875OnOn1iRJQPhBC6ndzCMNz2VgnwctP8G6jc.kew3oJoCjJr-2TzbFEiFbmbgEn7fXFn8zxEu3qpZ20Cy4ziyi1yP26rwAQ~0866fb2a73eea4aca8200ee0c63e820d

Analysts' recommendations: Codexis, Inc.

24-08-19	Benchmark Capital Downgrades Codexis to Hold From Buy	MT
24-05-30	Cantor Fitzgerald Starts Codexis With Overweight Rating, $11 Price Target	MT
24-02-29	Benchmark Upgrades Codexis to Buy From Hold, Price Target is $9	MT
23-11-07	Benchmark Downgrades Codexis to Hold From Buy	MT
23-11-06	Piper Sandler Trims Price Target on Codexis to $10 From $14, Maintains Overweight Rating	MT
23-08-14	Stifel Adjusts Price Target on Codexis to $5 From $9, Maintains Buy Rating	MT
23-05-09	Benchmark Adjusts Price Target on Codexis to $9 From $15, Keeps Buy Rating	MT
23-05-09	HC Wainwright Downgrades Codexis to Neutral From Buy	MT
23-02-27	HC Wainwright Adjusts Price Target on Codexis to $9 From $15, Keeps Buy Rating	MT
23-01-19	Piper Sandler Adjusts Price Target on Codexis to $23 From $22, Maintains Overweight Rating	MT
22-11-07	HC Wainwright Adjusts Price Target on Codexis to $15 From $25, Maintains Buy Rating	MT
22-08-08	HC Wainwright Adjusts Codexis' Price Target to $25 From $27, Reiterates Buy Rating	MT
22-07-18	HC Wainwright Adjusts Codexis' Price Target to $27 from $38, Keeps Buy Rating	MT
22-07-15	Cowen & Co Adjusts Codexis Price Target to $21 From $39, Maintains Outperform Rating	MT
22-07-15	Piper Sandler Adjusts Codexis' Price Target to $22 From $35, Reiterates Overweight Rating	MT
21-11-05	HC Wainwright Adjusts Price Target on Codexis to $38 From $33, Maintains Buy Rating	MT
21-10-15	Codexis : HC Wainwright Adjusts Codexis' Price Target to $33 from $28, Keeps Buy Rating	MT
21-08-06	Codexis : Piper Sandler Adjusts Codexis' Price Target to $34 From $32, Maintains Overweight Rating	MT
21-06-18	Codexis : HC Wainwright Adjusts Codexis' Price Target to $27 From $26, Keeps Buy Rating	MT
21-04-12	Codexis : Piper Sandler Starts Codexis at Overweight With $32 Price Target	MT
21-03-01	Codexis : Stifel Starts Codexis at Buy with $30 Price Target	MT
21-02-26	Codexis : HC Wainwright Adjusts Codexis' Price Target to $26 From $21, Maintains Buy Rating	MT
20-12-30	Codexis : Benchmark Capital Adjusts Codexis PT to $29 From $21, Maintains Buy Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CODEXIS, INC.					+281.53%
	LONZA GROUP AG					+15.88%
	REVOLUTION MEDICINES, INC.					+6.57%
	IQVIA HOLDINGS INC.					+5.74%
	BEONE MEDICINES AG					+16.18%
	CELLTRION, INC.					+37.13%
	MEDPACE HOLDINGS, INC.					-6.16%
	ASCENDIS PHARMA A/S					+24.17%
	EUROFINS SCIENTIFIC SE					-1%
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.					-5.89%
	Average					+37.41%
	Weighted average by Cap.					+12.57%